Screener
Madrigal Pharmaceuticals, Inc. MDGL Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales | 40,007 | 9,065 | 66,854 | 13,578 |
| Research and development | 91,178 | 54,081 | 199,870 | 98,253 |
| Selling, general and administrative | 289,375 | 196,858 | 557,896 | 364,734 |
| Total operating expenses | 420,560 | 260,004 | 824,620 | 476,565 |
| Loss from operations | (56,308) | (47,202) | (149,031) | (126,513) |
| Interest income | 7,104 | 8,227 | 15,347 | 17,597 |
| Interest expense | (7,940) | (3,264) | (15,759) | (6,561) |
| Other expense, net | (795) | (42) | (2,887) | (42) |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s other operating expenses?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported other operating expenses of $420.56M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s other operating expenses increased by 61.8% year-over-year, from $260M to $420.56M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s other operating expenses has grown at a 50.9% compound annual growth rate (CAGR), from $242.48M to $1.26B.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude